Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolperisone in Acute Back Muscle Spasm
NCT04671082Phase 3Completed
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tolperisone in back pain and Muscle spasm (4 arms), sponsored by Neurana Pharmaceuticals, Inc. Primary endpoint: Numerical Rating Scale for Pain at Day 14. Started Dec 2020; status: completed.
02
Drugs
tolperisone
03
Conditions
back painMuscle spasm
Beyond the preview
Go deeper on NCT04671082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671082.